Matthew Old O MD


Matthew Old O MD
Asst ProfessorCollege of
B-217 Starling Loving Hall 320 W 10th Avenue Columbus Ohio 43210
Phone:614-293-8074Fax: (614) 293-3193
  • Non-Member

General Research Interest

Dr. Old’s research interests are oncolytic viral therapy, HPV and head and neck cancer, and novel therapeutics for head and neck cancer including hyperbaric oxygen. His research lab focuses on novel therapeutics for head and neck cancer. In addition, Dr. Old is working to open multiple clinical trials with oncolytic viruses for head and neck cancer and metastatic disease.

Current Publications

  • Durmus K, Patwa HS, Gokozan HN, Kucur C, Teknos TN, Agrawal A, Old MO, Ozer EFunctional and quality-of-life outcomes of transoral robotic surgery for carcinoma of unknown primary.Laryngoscope 124 2089-95 9/1/2014
  • Xie X, Piao L, Cavey GS, Old M, Teknos TN, Mapp AK, Pan QPhosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.Oncogene 33 2040-52 4/17/2014
  • Arshad H, Ozer HG, Thatcher A, Old M, Ozer E, Agarwal A, Jafari H, Birkheimer D, Basinger H, Forest LA, Schuller DE, Teknos TNIntensive care unit versus non-intensive care unit postoperative management of head and neck free flaps: comparative effectiveness and cost comparisons.Head Neck 36 536-9 4/1/2014
  • Cunningham LC, Yu JG, Shilo K, Tang B, Nair L, Daniel VC, Old MOThymoma and parathyroid adenoma: false-positive imaging and intriguing laboratory test results.JAMA Otolaryngol Head Neck Surg 140 369-73 4/1/2014
  • Agrawal A, Ozer E, Schuller DE, Teknos TN, Pan Q, Zhang M, Kumar B, Piao L, Xie X, Schmitt A, Arradaza N, Cippola M, Old MElevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.Cancer 120 992-1001 4/1/2014
  • Santaliz-Ruiz LE, Xie X, Old M, Teknos TN, Pan Q, James AG, Solove RJEmerging role of nanog in tumorigenesis and cancer stem cells.Int J Cancer in press 12/21/2013
  • Kasemsiri P, Prevedello DM, Otto BA, Old M, Ditzel Filho L, Kassam AB, Carrau RLEndoscopic endonasal technique: treatment of paranasal and anterior skull base malignancies.Braz J Otorhinolaryngol 79 760-79 11/1/2013
  • Dziegielewski PT, Teknos TN, Durmus K, Old M, Agrawal A, Kakarala K, Marcinow A, Ozer ETransoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.JAMA Otolaryngol Head Neck Surg 139 1099-108 11/1/2013
  • Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal AUse of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.JAMA Otolaryngol Head Neck Surg 139 895-902 9/1/2013
  • Kaka AS, Kumar B, Kumar P, Wakely PE Jr, Kirsch CM, Old MO, Ozer E, Agrawal A, Carrau RE, Schuller DE, Siddiqui F, Teknos TNHighly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.Oral Surg Oral Med Oral Pathol Oral Radiol 116 327-35 9/1/2013
  • Tassone P, Old M, Teknos TN, Pan Qp53-based therapeutics for head and neck squamous cell carcinoma.Oral Oncol 49 733-7 8/1/2013
  • Kasemsiri P, Solares CA, Carrau RL, Prosser JD, Prevedello DM, Otto BA, Old M, Kassam ABEndoscopic endonasal transpterygoid approaches: anatomical landmarks for planning the surgical corridor.Laryngoscope 123 811-5 4/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: